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DIALYSIS – TRANSPLANTATION
Significance of minimodeling in dialysis patients with adynamic
bone disease
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Significance of minimodeling in dialysis patients with adynamic
bone disease.
Background. We previously concluded from histomorpho-
metric analysis that minimodeling contributes to bone for-
mation in adynamic bone disease in patients with primary
hypoparathyroidism. Presently we investigated whether this
mechanism might be peculiar to adynamic bone disease.
Methods. We histomorphometrically analyzed bone spec-
imens obtained at biopsy or autopsy from 26 maintenance
hemodialysis patients with hyperparathyroidism necessitating
parathyroidectomy (group A) and from 27 dialysis patients
with hypoparathyroidism (group B); respective mean ages were
60 ± 7 years vs. 64 ± 8 years; dialysis duration 14 ± 6 years vs.
11 ± 9 years; and serum intact parathyroid hormone (PTH) 1205
± 439 pg/mL vs. 41 ± 27 pg/mL. Group B was divided further
into outpatient and inpatient subgroups.
Results. By histomorphometry, group A patients were diag-
nosed with osteitis fibrosa, and those in group B with adynamic
bone disease. Minimodeling bone volume and minimodeling
bone number were significantly greater in group B than group A
(P = 0.0028 and P = 0.0008, respectively). Minimodeling bone
volume correlated significantly and positively correlated with
total bone volume in group B (P = 0.0016), but not in group A.
In group B, minimodeling bone volume and total bone voluem
were greater in outpatients than inpatients (P < 0.0001 and P
= 0. 025, respectively). Minimodeling bone volume and total
bone volume showed significant negative correlation with age
in group B (P < 0.001 and P = 0.005, respectively).
Conclusion. Minimodeling might contribute to bone forma-
tion in dialysis patients with adynamic bone disease, in the
absence of remodeling stimulated by parathyroid hormone
(PTH), especially in relatively young patients with good activi-
ties of daily living.
Idiopathic adynamic bone disease associated with low
serum parathyroid hormone (PTH) concentrations is a
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type of renal osteodystrophy occurring in dialysis pa-
tients. This bone disease has been noted particularly in
elderly individuals, diabetic patients, and patients under-
going chronic ambulatory peritoneal dialysis (CAPD) [1].
Elevating serum plasma calcium levels by administering
calcitriol and calcium carbonate may foster development
of adynamic bone disease in these patients [2]. Several
reports have suggested a close relationship between in-
creased incidence of hip and vertebral fractures in dial-
ysis patients and adynamic bone disease [3–5]. Reduced
bone mineral density in patients with adynamic bone dis-
ease has been postulated to predispose to fracture [3].
However, several studies form no relationship between
hypoparathyroidism and low bone mineral density [6, 7].
Whether adynamic bone disease itself causes fractures is
controversial. London et al [8] recently found that the
arterial calcification in end-stage renal disease (ESRD)
patients is associated with adynamic bone disease.
To clarify the pathophysiology of adynamic bone dis-
ease, we previously investigated bone morphology and
metabolism in two patients with primary hypoparathy-
roidism who long had shown low PTH concentrations.
In both, histomorphometric analysis yielded values con-
sistent with a diagnosis of adynamic bone disease. How-
ever, normal bone was diagnosed because bone volume
was preserved and dense bone-trabecular connectivity
was noted, with normal lamellar structure. We found that
in these cases bone formation is supported by a mech-
anism called “minimodeling,” which is characterized by
hump-like structures [9]. We next examined whether min-
imodeling took place in a patient with secondary hy-
poparathyroidism treated with hemodialysis for 30 years.
We found adynamic bone disease to be associated with
bone formation by minimodeling in this patient, although
trabecular connectivity was poor and bone islands were
relatively prominent [9].
Presently, to determine whether minimodeling is a
specific characteristic of adynamic bone disease, we
compared minimodeling bone volume between dialy-
sis patients with hyperparathyroidism requiring parathy-
roidectomy and patients with hypoparathyroidism. Next
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we examined whether ability to carry out activities of
daily living and age also influenced minimodeling bone
volume among the patients with hypoparathyroidism.
METHODS
Patient characteristics
Bone specimens were collected from both biopsies and
autopsies from 1997 to 2003. Patients with hyperparathy-
roidism necessitating parathyroidectomy (group A) (N =
26) included 13 men and 13 women; ages ranged from 49
to 69 years (mean ± SD, 60 ± 7 years). These patients
had been treated with hemodialysis from 4 to 24 years
(14 ± 6 years). Six patients were diabetic, while 20 were
nondiabetic. Group A patients were regularly treated in
the outpatient dialysis clinic.
Patients with hypoparathyroidism (group B) (N = 27)
included 14 men and 13 women, with ages ranging from
49 to 77 years (mean ± SD, 64 ± 8 years). Patients had un-
dergone dialysis for 4 to 30 years (11 ± 9 years). Diabetic
patients numbered 7, while 20 patients were nondiabetic.
Patients who had undergone parathyroidectomy were not
included. No patient had a pathologic fracture. Group B
patients were divided into two subgroups: patients regu-
larly treated in the outpatient dialysis clinic (group B1)
and patients regularly treated in the inpatient dialysis fa-
cility (bed-bound institutionalized patients) (group B2).
Group B2 patients were more malnutritional and more
severely ill or complicated with comorbid events than
group A and B1 patients. Eleven of the 14 patients in the
group B1 were treated in the outpatient dialysis clinic to
just before death (mainly due to cardiovascular and cere-
bral vascular events). Patients in group B1 numbered 14
(four diabetic patients and ten nondiabetic) and had ages
from 49 to 71 years (mean ±SD, 63 ± 10 years). Patients
in group B2 numbered 13 (three diabetic patients and
ten nondiabetic) and had ages from 60 to 77 years (mean
±SD, 68 ± 8 years).
Parathyroid tissue was surgically removed (parathy-
roidectomy) in group A patients with severe hyper-
parathyroidism due to hypercalcemia [11.6 ± 0.7 (10.2 to
13.5)] of serum calcium (mg/dL) adjusted by the formula
[serum calcium (mg/dL) − albumin (g/dL) + 4.0] and
hyperphosphatemia [8.7 ± 1.1 (7.1 to 10.0) mg/dL] who
were resistant to the treatments with calcium-containing
phosphorus binders and vitamin D derivatives.
Group B hypoparathyroid patients were administered
therapeutic agents such as calcium-containing phospho-
rus binders and vitamin D derivatives. The serum cal-
cium level was 10.2 ± 0.7 (8.8 to 11.5) of the measured
level of serum calcium (mg/dL) adjusted by the formula
[serum calcium (mg/dL) − albumin (g/dL) + 4.0]; the
serum phosphate level was 5.1 ± 1.0 (3.2 to 7.2) mg/dL.
Three out of 27 patients were administered 1 to 2 g of
aluminum-chelating agents per day. However, we did not
inspect the aluminum deposition in bone. We made this
decision in view of the very low level of serum aluminum
[8.6 ± 7.2 (0 to 29) lg/L] and the absence of any clinically
significant effects from aluminum intoxication in this time
period.
Right iliac bone biopsy was performed after double
tetracycline labeling according to the following schedule
in all patients included in the A group: 03 (on medicine)
and 14 (off medicine) and 03 (on medicine) and 14 (off
medicine). Twenty-four of the 27 patients in group B were
evaluated based on the right iliac bone specimens ob-
tained at autopsy without previous double labeling by
tetracycline. The other three patients underwent biopsy
after tetracycline administration.
The blood samples from the biopsied cases were taken
prior to heparinization in hemodialysis on the day before
the bone biopsy. The blood samples from the autopsied
cases were taken prior to heparinization in hemodialysis
within 1 month before the autopsy. Plasma intact PTH
concentration were determined with an immunoradio-
metric assay (IRMA) (Nichols Institute Diagnostics, San
Clemente, CA, USA). Bone Gla protein (BGP) (osteo-
calcin) also was measured with IRMA.
Bone specimen processing and examination
Undecalcified thin sections 5 lm in thickness were pre-
pared from bone specimens and stained by the Villanueva
method. Sections were observed with an epifluorescence
microscope using ultraviolet excitation. In a portion of
bone trabecula magnified at ×160, parameters were mea-
sured directly with an image analysis system linked to a
microcomputer.
Quantitative histomorphometric analysis of trabecu-
lar bone remodeling was carried out using the following
calculations:
Total bone volume(BV/TV)
= [bone volume(BV)/tissue volume(TV)] × 100(%)
Osteoid volume(OV/BV)
= [osteoid volume(OV)/bone volume(BV)] × 100(%)
Eroded surface(ES/BS)
= [eroded surface(ES)/bone surface(BS)] × 100(%)
Osteoclast number(N Oc/BS)
= [osteoclast number(N Oc)/bone surface(BS)]
× 100(N/mm)
The osteoclast number was calculated by one layer. The
osteoclast diameter ranged from 35 to 55 lm in group A
and 20 to 30 lm in group B.
Fibrous tissue volume(Fb V/TV)
= [fibrous tissue volume(Fb V)/tissue volume(TV)]
× 100(%)
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Fig. 1. Minimodeling characterized by hump-like structure (arrows).
Polarizing microscopy ×200.
Sites of cancellous bone formation were classified as
showing either remodeling or minimodeling. A remod-
eling site was defined as a scalloped cement line with
interrupted collagen fibers in the adjacent bone underly-
ing the bone formation site, thus indicating previous bone
resorption. Minimodeling sites were defined as bone for-
mation sites with smooth cement lines without interrup-
tion of surrounding collagen fibers, showing no evidence
of previous bone resorption [10] (Fig. 1). Lamellar bone
and woven bone were observed in a mixed pattern on the
biopsied bone specimens of the patients with secondary
hyperparathyroidism. Minimodeling was observed on the
surface of the lamellar bone, but not the woven bone.
Accordingly, minimodeling was measured as a part of
lamellar bone. Bone histomorphometry concerning min-
imodeling used the following calculations:
Minimodeling bone volume (Mi Mo BV/BV)
= [absolute minimodeling bone volume (Mi Mo BV)/
bone volume (BV)] × 100(%)
Minimodeling bone number(N Mi Mo/BV)
= [absolute minimodeling bone number(N Mi Mo)/
bone volume(BV)](N/mm2)
Statistical analysis
Results are expressed as mean ± SD. Statistical anal-
ysis was performed using StatView version 5.0 for Mac-
intosh (Apple Computers Japan, Inc., Shinjuku, Tokyo,
Japan). Differences between groups were compared us-
ing the Mann-Whitney U test for nonnormally distributed
variables, while normally distributed variables were com-
pared using unpaired t tests. To evaluate the relationship
between variables, Pearson’s correlation coefficient was
used for normally distributed variables, while Spearman’s
ranked correlation coefficient was used when variables
were nonnormally distributed. A P value less than 0.05
was considered to indicate significance.
RESULTS
Table 1 compares between patients with hyperparathy-
roisism (group A) and with hypopararhyroidism (group
B). In group A, plasma intact PTH and BGP were sig-
nificantly higher than in group B. The osteoid volume
(OV/TV), eroded surface (ES/BS), osteoclast number (N
Oc/BS) and fibrous tissue volume (Fb V/TV) were signif-
icantly greater in hyperparathyroid patients (group A)
than in hypoparathyroid patients (group B), reflecting a
difference in histologic diagnosis of bone. All of the hy-
perparathyroid patients (group A) were diagnosed with
osteitis fibrosa, while 3 of 27 hypoparathyroid patients
(group B) were diagnosed with adynamic bone disease
according to the previously reported criteria [11]. The fol-
lowing factors led us to conclude that the other 24 patients
were compatible with adynamic bone without measure-
ment of the bone formation rate by technetium labeling.
The total osteoid volume was small (<15%), the fibrous
tissue was very scant (<0.5%), the eroded surface was de-
creased, and the numbers of osteoblasts and osteoclasts
were both decreased.
Minimodeling bone volume and minimodeling bone
number were significantly greater in hypoparathyroid pa-
tients (group B) than in the hyperparathyroid patients
(group A) (P = 0.0028 and P = 0.0008, z score = −2.85
and z score = −3.75, respectively). The distribution of
minmodeling bone volume on patients of both groups is
shown in Figure 2.
To investigate whether bone volume apparently
formed by minimodeling is associated with total bone
volume, the correlation between minimodeling bone
volume and total bone volume in patients with hy-
poparathyrodism (group B) was analyzed. Minimodel-
ing bone volume showed a significant positive correlation
with total bone volume (r2 = 0.304, P = 0.0016) (Fig. 3).
On patients with hyperparathyrodism (group A), no cor-
relation was found between minimodeling bone volume
and total bone volume (P = 0.66) (Fig. 4). These results
suggest that minimodeling contributes to preseration of
bone volume in patients with hypoparathyroidism, but
not in those with hyperparathyroidism.
We considered the contribution of activities of daily
living status to minimodeling in patients with hy-
poparathyroidism. Minimodeling bone volume and total
bone volume were compared between outpatient dial-
ysis and inpatient dialysis patient populations (Figs. 5
and 6). Minimodeling bone volume and total bone vol-
ume in outpatients (group B1) were significantly greater
than in inpatients (group B2) with hypoparathyroidism
(P < 0.0001 and P = 0,025, z score = −3.43 and z
score =−2.29, respectively). Thus, good activities of daily
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Table 1. Comparison between hyperparathyroidism (group A) and hypoparathyroidism (group B)
Hyperparathyroidism (group A) Hypoparathyroidism (group B) P value z score
Number 26 27
Age years 60 ± 7 64 ± 8 0.13 −1.52
Hemodialysis duration years 14 ± 6 11 ± 9 0.07 −1.83
Intact parathyroid hormone pg/mL 1205 ± 439 41 ± 27 <0.0001 −6.42
Bone Gla protein (BGP) ng/mL 334 ± 208 26 ± 40 <0.0001 −5.82
Tissue volume (TV) mm2 14.3 ± 4.6 20.4 ± 6.9 0.0054 −2.78
Bone volume (BV) mm2 3.5 ± 1.7 2.9 ± 1.5 0.1574 −1.05
Bone volume (BV/BV)% 24.7 ± 8.2 14.3 ± 6.3 0.0019 −3.96
Osteoid volume (OV/BV)% 7.9 ± 5.6 2.66 ± 3.08 0.0003 −3.98
Eroded surface (ES/BS)% 27.6 ± 10.3 10.4 ± 7.9 <0.0001 −4.63
Osteoclast number (N Oc/BS) N/mm 1.1 ± 1.3 0.19 ± 0.23 <0.0001 −4.70
Fibrous tissue volume (Fb V/TV)% 6.1 ± 7.9 0.15 ± 0.24 <0.0001 −6.25
Minimodeling bone volume (Mi Mo BV/BV% 1.44 ± 1.08 3.65 ± 2.96 0.0028 −2.85
Minimodeling bone number (N mi Mo/BV) N/mm2 1.63 ± 1.17 5.34 ± 4.54 0.0008 −3.75
Mi Mo BV/N Mo mi BV lm2 11,748 ± 8199 8351 ± 4276 0.23 −1.38
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Fig. 2. Comparative study of minimodeling bone volume (Mi Mo
BV/BV) between patients with hyperparathyroidism necessitating
parathyroidectomy and patients with hypoparathyroidism. Results are
expressed as means ± SD. Minimodeling bone volume in the hy-
poparathyroidism group was significantly greater than in the hyper-
parathyroidism group (P = 0.0028, z score = −2.85).
14
12
10
8
6
4
2
0
−2
M
in
im
od
el
in
g 
bo
ne
 vo
lu
m
e 
(M
i M
o B
V/
BV
), %
0 5 10 15 20 25 30 35
Total bone volume (BV/TV), %
Fig. 3. Correlation between minimodeling bone volume (Mi Mo
BV/BV) and total bone volume (BV/TV) in patients with hypoparathy-
roidism. Minimodeling bone volume showed a significant positive cor-
relation with total bone volume (r2 = 0.304, P = 0.0016).
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Fig. 4. Correlation between minimodeling bone volume (Mi Mo
BV/BV) and total bone volume (BV/TV) in patients with hyperparathy-
roidism. No significant correlation was found between these two vari-
ables (P = 0.66).
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Fig. 5. Comparison of minimodeling bone volume (Mi Mo BV/BV) be-
tween patients with hypoparathyroidism treated with dialysis as outpa-
tients (group B1) and those treated with dialysis as long-term inpatients
(group B2). Results are expressed as mean ± SD. Minimodeling bone
volume was significantly higher than in the latter group (P < 0.0001, z
score = −3.43).
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Fig. 6. Comparison of total bone volume (BV/TV) between patients
with hypoparathyroidism treated with dialysis as outpatients (group
B1) and those treated with dialysis as long-term inpatients (group B2).
Results are expressed as means ± SD. Total bone volume in the former
group was significantly higher than in the latter group (P = 0.025, z
score = −2.29).
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Fig. 7. Correlation between minimodeling bone volume (Mi Mo
BV/BV) and age in patients with hypoparathyroidism, Minimodel-
ing bone volume showed significant (negative) correlation with age
(r2 = 0.208, P < 0.001).
living status may contribute to formation of bone via
minimodeling.
We also examined correlations of minimodeling bone
volume and total bone volume with age in patients with
hypoparathyrodism (Figs. 7 and 8). Both minimodeling
bone volume and total bone volume showed a signifi-
cant negative correlation with age (P < 0.001 and P =
0.005, respectively). Minimodeling bone volume and to-
tal bone volume were compared between male and fe-
male hypoparathyroid patients. No significant correlation
was found between men and women in the minimodeling
bone volume or total bone volume (P = 0.69 and P =
0.37, respectively).
Thus, relatively young age may contribute to bone for-
mation via minimodeling.
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Fig. 8. Correlation between total bone volume (BV/TV) and age in pa-
tients with hypoparathyroidism. Total bone volume showed significant
(negative) correlation with age (r2 = 0.35, P = 0.005).
DISCUSSION
Various bone lesions occurring in patients with chronic
renal failure share the general name of renal osteodys-
trophy. Adynamic bone disease represents an additional
type of low-turnover bone disease, characterized clini-
cally by a low serum PTH concentration, and histolog-
ically by low bone turnover, absence of fibrous tissue,
a small amount of osteoid, and a decrease in osteoclast
numbers.Adynamic bone disease is distinguished from
osteomalacia by a lack of an increase in osteoid volume
associated with a delay in its mineralization. Adynamic
bone disease is distinct from the mild type of renal os-
teodystrophy because of the decreased bone formation
rate in adynamic bone disease. Initially, adynamic bone
disease was reported to be associated with aluminum de-
position; after aluminum-containing phosphate-binding
preparations were replaced by calcium carbonate and a
reverse osmotic apparatus was adopted for processing
water for dialysate, exposure to aluminum has been min-
imized [12–14], and the existence of idiopathic adynamic
bone disease has become evident. Although the etiology
of idiopathic adynamic bone disease is uncertain, this dis-
ease has been reported to be more prevalent in patients
undergoing CAPD, elderly persons, and diabetic patients
[1]. Adynamic bone disease in CAPD is believed to re-
flect maintenance of higher plasma calcium concentra-
tion. Excessive administration by calcitriol and calcium
carbonate may contribute directly to adynamic bone dis-
ease [2].
To better understand adynamic bone disease, we pre-
viously performed histomorphometric bone analysis in
two patients with primary hypoparathyroidism who had
shown low circulating PTH level for many years. Can-
cellous trabecular bone showed findings of adynamic
bone disease, including paucity of tetracycline labeling
(decreased bone formation rate), a decrease in both
osteoblasts and osteoclasts, scant osteoid, and absence
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of fibrous tissue; Mineralized bone volume, however, was
abundant [9, 11]. Since evidence of the minimodeling phe-
nomenon was present in these two cases and tetracycline
labeling occurred in an area with minimodeling, bone for-
mation by this mechanism may have been responsible for
preserving bone volume despite hypoparathyroidism and
very slow bone formation rate [9].
Next, to elucidate whether this minimodeling mecha-
nism was limited to primary hypoparathyroidism or also
would be applicable to patients with true adynamic bone
disease developing following initiation of dialysis, we per-
formed bone histomorphometry in an autopsy case where
the patient had undergone hemodialysis for 30 years,
while maintaining low serum PTH concentrations over a
long period. This case differed morphologically from the
first two in that bone trabecular connectivity was poor, is-
land bone was prominent and woven bone was apparent
only in small areas. An adynamic state of bone could be di-
agnosed according to reported criteria [11]. Bone volume
was preserved according to both histomorphologic anal-
ysis and bone mineral density measurement using dual-
energy x-ray absorptiometry (DEXA). Hump-like bone
formations indicating minimodeling were evident [9].
Formation of cancellous bone may occur according
to both remodeling and minimodeling mechanisms. In
remodeling, bone formation by osteoblasts occurs only
where bone resorption by osteoclasts has occurred previ-
ously [15].Remodeling is regulated systemically by PTH,
1,25-dihydroxyvitamin D, and by other hormones. In
minimodeling, however, bone formation resulting from
osteoid deposition and successive mineralization appar-
ently occurs at a quiescent bone surface without prior
bone resorption by osteoclasts; newly formed bone there-
fore protrudes from older bone. In this process, activities
of osteoblasts and osteoclasts are dissociated. Linear di-
viding lines between newly formed bone and old bone
can be observed as “lamellar separation.” This demarca-
tion is clear in early stages, but soon becomes obscure
as the minimodeling site is integrated with the preexist-
ing bone. Minimodeling is reported to be regulated by
dynamic external stress according to Wolff’s law [16–19].
While we proposed the occurrence of minimodeling
in our previous studies of only a few hypoparathyroid
patients [9], whether minimodeling was specific to hy-
poparathyroidism remained at issue. In the present in-
vestigation we therefore compared minimodeling bone
volume between dialysis patients with very high and with
low PTH. Minimodeling bone volume was greater in pa-
tients in a low-PTH state than in those with high PTH,
suggesting that minimodeling gives way to active remod-
eling in a high PTH state. However, once remodeling
diminishes because of paucity of PTH, the minimodel-
ing mechanism may be activated. We further noted that
in hypoparathyroid dialysis patients, both minimodel-
ing bone volume and total bone volume were greater in
patients with relatively unimpaired activities of daily liv-
ing(outpatients) than in those with more impaired activ-
ities of daily living(long-term inpatients). Minimodeling
bone volume and total bone volume also were smaller in
the elderly. Accordingly, among patients with adynamic
bone disease reflecting low PTH, bone volume would be
lost in immobilized individuals with extremely limited ex-
ercise because minimodeling would not be stimulated. On
the other hand, bone volume could be preserved in the
presence of adynamic bone disease when exercise was
sufficient to stimulate minimodeling.
The significance of minimodeling initially attracted lit-
tle discussion after the phenomenon was proposed by
Frost [16–19]. More recently minimodeling gradually has
come to receive greater attention. Erben [20] reported
that growth of cancellous bone depended upon minimod-
eling while rats were growing, but maintenance of can-
cellous bone depended upon remodeling when rats were
aging. Kobayashi et al [10] studied minimodeling in iliac
bone biopsy specimens obtained from 27 postmenopausal
women who underwent total hip arthroplasty. Because
these patients had no apparent metabolic disorders such
as renal function abnormalities, they did not have renal
osteodystrophy. Minimodeling was present in 17 of 27, be-
ing absent in ten. Minimodeling bone volume, however,
was very small (0.71 ± 1.2%). Patients with minimodeling
had higher mineral apposition rate (MAR) and BFR/BV
values than those without minimodeling. This suggests
that when PTH is presumably normal, minimodeling will
be minimal, but may contribute slightly to preservation
of bone volume by a minor increase in bone formation
rate.
CONCLUSION
Remodeling, regulated directly by PTH, has been con-
sidered a main mechanism of bone formation in renal
osteodystrophy. More complete understanding of the
minimodeling mechanism regulated by dynamic exter-
nal stress obtained from future studies may yield clues
to bone formation mechanisms in various forms of renal
osteodystrophy, including adynamic bone disease.
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